-
Edmund Richardson Wins Baillie Gifford Prize for 'Alexander' Biography
-
Pakistan Demands Grant-Based Climate Finance at COP31 to Avoid Debt Trap
-
BYD Drops Rotating Screens in New Models Due to Tech Limits
-
E Pellicci Pop-Up at Selfridges Brings Back Nostalgic School Cake
-
Ryanair Flight from Rome Makes Emergency Landing in Lisbon After Bomb Threat
-
Coronation Street's Debbie Webster Steps Down as Dementia Storyline Intensifies
-
Maltese President Visits London Hospital to Support Families Facing Medical Care Challenges
Featured
Last news
Champion Safe Utah Factory Transformation Takes Shape as Major Lean Realignment Moves Forward
Champion Safe is advancing the major physical transformation of its Utah manufacturing operation announced in September, with the factory realignment now actively taking shape. The project is reorganizing the manufacturing floor around a more efficient production flow designed to support greater throughput, lower costs and more consistent fulfillment. The work represents continued execution of Champion's broader strategy to strengthen manufacturing and build a more scalable operating platform.
Genomate and VivaMed to Rescue and Repurpose Oncology Drugs with AI and Clinical Data
The collaboration aims to identify and advance new oncology drug candidates.
As EPA PFAS Drinking Water Deadlines Approach, 374Water Positions Air-SCWO to Permanently Destroy Spent GAC and Ion Exchange Media
4 ppt limits for PFOA and PFOS are driving a multi-year buildout of carbon and resin treatment across the US, and a growing, recurring stream of PFAS-laden spent media poses ongoing liabilities, if not destroyed
Organto Foods Provides Business Updates
Presenting at Planet Microcap Toronto 2026 Conference on October 28th
Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
NEWARK, CA / ACCESS Newswire / October 27, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that senior management will participate in four investment bank conferences taking place in November 2026.
Melex Technologies Inc. Launches Simple Life Science, a Life Science Company Supplying Peptide and Small Molecule API and Custom Synthesis to Laboratories
DELRAY BEACH, FL / ACCESS Newswire / October 27, 2026 / Melex Technologies Inc. today announced Simple Life Science (simplelifescience.com), a life science company serving laboratories and research organizations. Simple Life Science supplies peptide and small molecule active pharmaceutical ingredient (API), custom synthesis and analytical services. All peptides and API it sells are for laboratory research use only and are not for human or animal consumption.
Pivotree to Release Third Quarter 2026 Financial Results
TORONTO, ON / ACCESS Newswire / October 27, 2026 / Pivotree Inc. (TSXV:PVT) ("Pivotree" or the "Company"), a leading provider of frictionless commerce solutions, will release third quarter 2026 financial results on Tuesday, November 17, 2026 before the market opens. The webinar will be hosted by Bill Di Nardo, CEO, and Mo Ashoor, CFO, followed by a question and answer period.
YMC America Connects Chromatography Customers with Published Research Through Bioz Badges
PALO ALTO, CA / ACCESS Newswire / October 27, 2026 / Bioz, Inc., a scientific intelligence platform that uses citation data to show how products are used in published research, has been selected by YMC America, a provider of chromatography products and purification technologies, to bring publication-backed evidence to its website through Bioz Badges. The integration gives scientists immediate access to relevant research publications as they evaluate YMC products for their separation and purification workflows.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 27
LONDON, UK / ACCESS Newswire / October 27, 2026 / The Company announces that on 26 October 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
French court adjourns trial over 2020 death of delivery driver
A French court on Monday adjourned the trial of three police officers for the 2020 death of a man whose case drew comparisons to the George Floyd killing in the United States that sparked global demonstrations.
US singer Chris Brown avoids jail over London nightclub brawl
American singer Chris Brown avoided jail when sentenced by a UK court Monday after pleading guilty to a public order offence during a 2023 brawl at a London nightclub.
US singer Chris Brown avoids jail over UK nightclub brawl
American R&B singer Chris Brown avoided jail when sentenced by a UK court Monday after pleading guilty to a public order offence during a 2023 brawl at a London nightclub.
Canadian youth seek climate action in landmark trial
Fifteen young Canadians will try to prove the federal government has breached their rights through insufficient action on climate change in a landmark trial that opens Monday in the west coast city of Vancouver.
James Blunt reportedly sought extra underwear during Celebrity Traitors filming
James Blunt reportedly asked Celebrity Traitors production staff to buy additional underwear after running out during filming at Ardross Castle.
Marvin Smoot Named Chief Executive Officer of Missouri Valley Regional Medical Center
Experienced healthcare executive to lead continued growth, operational excellence, and expanded access to care across the region.
Simple Cosmetics Expands Its Skin Care and Hair Care Line at SimpleCosmeticsPro.com
BOCA RATON, FL / ACCESS Newswire / October 26, 2026 / Simple Cosmetics LLC today announced an expanded personal care line, sold online at simplecosmeticspro.com. The line includes skin care and hair care products. Copper Glow was first sold through Simple Peptide (simplepeptide.com), a sister business founded by the same team. More than 20,000 jars of Copper Glow Firming Cream have been sold, and the Simple Cosmetics store has completed more than 1,200 orders since May 2026.
Cenmed Establishes Strategic Presence at HELIX as Company Enters Next Phase of Growth
New Brunswick-based healthcare and life sciences company joins the HELIX innovation ecosystem as it expands its technology, services and capabilities
Watson's Acquires Tampa Bay Spas, Enters Tampa Bay Market
Acquisition adds three Florida locations, expands Watson's Florida footprint to seven stores, and advances plans to exceed 50 locations within the next 12-18 months.
Trustpoint Xposure Launches Real Estate AEO Program for Agents, Brokers, and Developers
A new program from Trustpoint Xposure builds AI search visibility for real estate professionals whose individual expertise goes unrecognized by ChatGPT, Gemini, and Perplexity despite strong brokerage affiliations and production records.
Aspira Plastic Surgery & Med Spa Offers Savings on Liposuction and Complimentary Consultations
Austin practice reduces the cost of SmartLipo and chin and jawline liposuction through November 30, with complimentary consultations available through December 31.
Dragonfleye Therapeutics Corp. Takes Flight, Raising US$37.5 Million in Private Placement Offerings to Advance Novel Ocular Platform-Based Treatments
TORONTO, ON / ACCESS Newswire / October 26, 2026 / Dragonfleye Therapeutics Corp. ("Dragonfleye" or the "Company"), a patient-centered, innovation-focused company developing minimally invasive treatments for pathologic conditions in ophthalmology using its platform technology, today announced that it completed two non-brokered private placements of common shares during 2026, raising aggregate gross proceeds of US$37.5 million (the "Offerings"). Participants included healthcare-dedicated investors and existing shareholders.
Chervon names Joel Petersheim as Vice President, End User Research and Sales - OPE Commercial USA
NAPERVILLE, IL / ACCESS Newswire / October 26, 2026 / Joel Petersheim joins Chervon as Vice President, End User Research and Sales - OPE Commercial, effective October 26, 2026, reporting to Joe Galli, CEO.
Chervon Names Parker Wesley Clary Director of Field Sales - Southern Division
NAPERVILLE, IL / ACCESS Newswire / October 26, 2026 / Parker Wesley Clary joins Chervon as Director of Field Sales - Southern Division, effective October 26, 2026, reporting to Thomas Kentouris, VP of Field Sales.
Chervon Names Maggie Jones Director of National Field Sales OPS
NAPERVILLE, IL / ACCESS Newswire / October 26, 2026 / Maggie Jones joins Chervon as Director of National Field Sales Operations, effective October 26, 2026, reporting to Thomas Kentouris, VP of Field Sales. Jones will be charged with building out the support system, technology platform, and rigorous measurement/control process for the Chervon Field Sales Network.
Medical Care Technologies Inc. (OTCID:MDCE) Subsidiary Real Game Used Maintains Steady Authentication Backlog
Automated Submission System Supports Continuous Customer and Auction Brand Work as Company Operates Multiple Revenue Streams
Hepion Pharmaceuticals Receives FDA Feedback Supporting a Path to Demonstrating Prophylactic Protection for GV104 Against Fentanyl-Induced Cardiac Arrest
- In a simulation of 200 virtual subjects, a single dose of GV104 (16 mg nalmefene buccal film) taken at least 15 minutes before exposure prevented every potential fentanyl-induced cardiac arrest, at intravenous fentanyl doses known to be lethal in humans -- FDA re-affirmed the overall approach and provided comments that will improve the Company's ability to "demonstrate long-term prophylactic protection" -- The FDA comments are an important step in the path leading to an NDA. The Company intends to submit its response promptly -
Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant
Ten patients initially deemed unfit for intensive chemotherapy proceeded to stem cell transplantTransplant rate compares favorably with historical standard-of-care experience, adding to growing clinical evidence supporting mipletamig's potential to improve outcomes in frontline AMLAptevo expects the RAINIER dose optimization trial to conclude by year-end, with FDA interaction and initiation of a Phase 2 clinical trial anticipated in the first half of 2027
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
Unsolicited Interest Reinforces Velocity's Strategic Value as Valion Bio Evaluates Opportunities to Advance Entolimod
ENvue Medical Issues Letter to Shareholders
Letter Highlights Inova Clinical Data, Hospital Customer Base and Leaner Operating Structure
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 26
Purchase of own shares
Serbia's student movement ousts longtime leader in parliament poll
Serbia's student-led movement declared victory in parliamentary elections Sunday ending 14 years in power for Aleksandar Vucic's right-wing populist party.
Serbia records bumper turnout as students challenge ruling party
Serbians voted in droves on Sunday in a snap parliamentary poll, raising hopes for its student-led movement seeking to unseat veteran leader Aleksandar Vucic’s ruling party.